Prescribing patterns of cardiovascular drugs in cardiology outpatient department in a tertiary care hospital in Western Odisha
Keywords:Prescription auditing, Rational drug use, Drug utilization study, Cardiology outpatient department, Prescribing indicators WHO
Background: Cardiovascular morbidity plays a villainous role globally as well as countries like India. Additionally, irrational prescription incurs greater damage to health and wellbeing. Drug utilization studies scrutinize the appropriateness of treatment and provide favorable feedbacks to strengthen clinical practices. The objective of the study was to describe treatment practices in cardiology outpatient and drug utilization pattern using core prescribing indicators by World Health Organization (WHO).
Methods: A cross-sectional, observational study of 4-month duration was undertaken for cardiology Outdoor patients at a tertiary care hospital. 615 prescriptions were screened and analyzed.
Results: Males (59.84%) were more in number than females (40.16%). Average number of the prescribed drugs per patient were 4.32±2.7 and (3.73±1.1 for cardiovascular drugs). Generic prescription was 60.98%. Percentage encounters with antibiotics 4.11, injectables 2.92%, fixed-dose combinations (FDCs) (11.8%) were documented. Drugs from the National List of Essential Medicines were 75.89%. The most common diagnosis was ischemic heart disease (68.29%). Hypolipidemics (78.25%) followed by antiplatelets (71.14%) were toppers in cardiovascular drug. Antiulcer drugs (PPI/Antacids) comprised 58.54% of total prescriptions.
Conclusions: Less adherence to EDL, less generic prescriptions, use of FDC are major shortcomings. Areas to further rationalization like optimal use of evidence based medication like beta-blockers, newer anticoagulants/anti-platelet agents and newer anti-anginal agents are identified.
Cardiovascular diseases (CVDs). Who.int. 2019. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed on 07 July 2020.
How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators - EDM Research Series No. 007: Chapter 2: Core drug use indicators: Group 1: Prescribing indicators. Apps.who.int. 2019. Available from: https://apps.who.int/medicine-docs/en/d/Js2289e/3.1.html. Accessed on 07 July 2020.
Sharma KK, Gupta R, Agrawal A. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Vascular Health and Risk Management. 2009;5:1007.
Ajay VS, Prabhakaran D. Coronary heart disease in Indians: implications of the INTERHEART study. Indian J Med Res. 2010;132(5):561-6.
Roy A, Biswal SB, Patel NK, Hota PS, Rath B. Utilization trends of drugs in patients admitted with ischemic heart disease in a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2020;9:956-61.
Veeramani VP, Muraleedharan AP. Study on drug utilization pattern in cardiology outpatient department at tertiary care hospitals in South India: A prospective multicenter cross-sectional observational study. Int J Med Sci Public Health. 2020;9(5):321-8.
Vinodkumar M, Ravishankar K, Aswinichand P, Satyanarayana V, Manoj GHRR, Bharath Kumar A. Drug utilization evaluation of cardiovascular drugs in outpatient department in a tertiary care hospital: A Descriptive Observational Study. Int J Cur R. 2015;7(9):20693-7.
George J, Devi P, Kamath DY, Anthony N, Kunnoor NS, Sanil SS. Patterns and determinants of cardiovascular drug utilization in coronary care unit patients of a tertiary care hospital. J Cardiovasc Dis Res. 2013;4(4):214-21.
Kamath A, Shanbhag T, Shenoy S. A Descriptive Study of the Influence of Age and Gender on Drug Utilization in Acute Myocardial Infarction. J Clin Diagnos Res. 2010;(4):2041-6.
Belhekar MN, Patel TC, Singh MK, Pandit PR, Bhave KA, Redkar NN. Evaluation of prescribing pattern of drugs use in patients of coronary artery disease at a tertiary care hospital. Int J Basic Clin Pharmacol. 2020;7(9):1792.
Slathia I, Jadhav PR, Deb P, Verma S. Drug utilization study in Cardiology outpatient department at a tertiary care hospital. Int J Basic Clin Pharmacol. 2017;6:2276-81.
Isah A, Laing R, Quick J, Mabadeje A, Santoso B, Hogerzeil H et al. The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators. West African Journal of Pharmacology and Drug Research. 2001;18(1).
National List of Essential Medicines (NLEM) 2015 – India. Apps.who.int. 2017. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js23088en/. Accessed on 07 July 2020.
Mayank PN, Vinson LG, Padmanabh VR. Fixed dose combinations to prescribe or not to prescribe: A dilemma of medical profession. Int J Basic Clin Pharm. 2014;3:105-13.